KSL-W

General Information


DRACP ID  DRACP03580

Peptide Name   KSL-W

Sequence  KKVVFWVKFK

Sequence Length  10

UniProt ID  Not available

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  DRACP03580

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C68H105N15O11

Absent amino acids  ACDEGHILMNPQRSTY

Common amino acids  K

Mass  146938

Pl  11.28

Basic residues  4

Acidic residues  0

Hydrophobic residues  6

Net charge  4

Boman Index  -179

Hydrophobicity  17

Aliphatic Index  87

Half Life 
  Mammalian: 1 hour
  Yeast: 2 min
  E.coli: 2 min

Extinction Coefficient cystines  5500

Absorbance 280nm  611.11

Polar residues  0

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 30508634

Title  Antimicrobial peptide KSL-W and analogues: Promising agents to control plant diseases

Doi Not available

Year  2018

Literature 2

Pubmed ID 26473368

Title  Synthesis and Evaluation of Biological Activity of Antimicrobial-Pro-Proliferative Peptide Conjugates

Doi Not available

Year  2015

Literature 3

Pubmed ID 25710035

Title  High In Vitro Antibacterial Activity of Pac-525 against Porphyromonas gingivalis Biofilms Cultured on Titanium

Doi Not available

Year  2015

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  7769

DRACP is developed by Dr.Zheng's team.